| CAS NO: | 1448346-43-7 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 50mg | 电议 |
| 500mg | 电议 |
AGI-14100 is a novel orally bioavailable mIDH1 inhibitor. Preclinical trials of AGI-14100 for the treatment of primary human myeloid leukemia therapy have been underway since 2013. References:
纯度：≥98%
CAS：1448346-43-7
m.cnreagent.com